In addition, oncogenic KRAS and transforming growth factor-beta (TGF-β) have been shown to promote and maintain CRC metastasis via the regulation of immunity and cell–cell contact (Boutin et al., 2017). This evidence concerns the gene KRAS and colorectal carcinoma.